NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹83 Cr | ₹91 Cr | ₹75 Cr | ₹105 Cr | ₹125 Cr |
What is the latest Contingent Liabilities ratio of NEULAND LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹83 Cr |
Mar2023 | ₹91 Cr |
Mar2022 | ₹75 Cr |
Mar2021 | ₹105 Cr |
Mar2020 | ₹125 Cr |
How is Contingent Liabilities of NEULAND LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹83 Cr | -9.48 | |
Mar2023 | ₹91 Cr | 22.14 | |
Mar2022 | ₹75 Cr | -28.68 | |
Mar2021 | ₹105 Cr | -16.46 | |
Mar2020 | ₹125 Cr | - |
Compare Contingent Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹15,708.3 Cr | -4.3% | 2.9% | 74.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,032.0 Cr | 0.9% | 2.2% | 23.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,252.0 Cr | 3.3% | 4.7% | 58% | Stock Analytics | |
CIPLA | ₹124,457.0 Cr | 0.5% | 2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,425.0 Cr | -0.4% | 2.8% | 24.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,152.8 Cr | -0.8% | -0.4% | 0.8% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -4.3% |
2.9% |
74.2% |
SENSEX | 0.9% |
3% |
8.9% |
You may also like the below Video Courses